Most of a clinical trial's budget pays for coordination, not science. Michelle Longmire, MD, shows how supervised agentic AI can take on that work, reaching the same milestone with about 42% less capital and far less waiting time.

‍

American biotechnology still leads in scientific innovation, but its advantage in turning science into medicine is eroding. Part 1 examines how slower, more expensive clinical development is shifting the competitive edge toward China, and what’s at stake for the future of U.S. biotech.

What exactly is a forward deployed engineer?

If you have spent any time around AI and enterprise software this year, you have probably heard the term FDE, or forward deployed engineer. It sounds like a buzzword, but the role is why we’re able to solve real problems for our clinical trial clients in record time.

‍